Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G DeBoer

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Molecular Biology|April 20, 1988
Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomeraseL S Ripley, J S Dubins, J G deBoer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
MYCN protein expression as a predictor of neuroblastoma prognosisH S Chan, B L Gallie, G DeBoer, et al.
The British Journal of Surgery|August 1, 1985
The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanomaP A Kersey, N A Iscoe, J A Gapski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancerJ P Sculier, R Feld, W K Evans, et al.
The Canadian Journal of Urology|March 9, 2004
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancerR Choo, V Do, L Sugar, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 1994
Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?N A Iscoe, C D Naylor, J I Williams, et al.
The New England Journal of Medicine|December 5, 1991
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastomaH S Chan, G Haddad, P S Thorner, et al.
Breast Cancer Research and Treatment|July 1, 1997
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1C A Sawka, K I Pritchard, W Shelley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology GroupF A Shepherd, R J Ginsberg, R Haddad, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1996
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapyB L Gallie, A Budning, G DeBoer, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Molecular Biology|April 20, 1988
Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomeraseL S Ripley, J S Dubins, J G deBoer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
MYCN protein expression as a predictor of neuroblastoma prognosisH S Chan, B L Gallie, G DeBoer, et al.
The British Journal of Surgery|August 1, 1985
The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanomaP A Kersey, N A Iscoe, J A Gapski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancerJ P Sculier, R Feld, W K Evans, et al.
The Canadian Journal of Urology|March 9, 2004
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancerR Choo, V Do, L Sugar, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 1994
Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?N A Iscoe, C D Naylor, J I Williams, et al.
The New England Journal of Medicine|December 5, 1991
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastomaH S Chan, G Haddad, P S Thorner, et al.
Breast Cancer Research and Treatment|July 1, 1997
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1C A Sawka, K I Pritchard, W Shelley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology GroupF A Shepherd, R J Ginsberg, R Haddad, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1996
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapyB L Gallie, A Budning, G DeBoer, et al.
Pageof 9